Aeluma, Inc.: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 10, 2024 and accepted by EDGAR at May 10, 2024, 14:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $343.9k | us-gaap:Revenues |
| Revenue | 9 months2023-07-01 to 2024-03-31 | $639.3k | us-gaap:Revenues |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $233.6k | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2023-07-01 to 2024-03-31 | $385.5k | us-gaap:CostOfRevenue |
| Research and development | 3 months2024-01-01 to 2024-03-31 | $620.3k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2023-07-01 to 2024-03-31 | $2.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | −$962.8k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-07-01 to 2024-03-31 | −$3.6m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2024-01-01 to 2024-03-31 | −$962.7k | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-07-01 to 2024-03-31 | −$3.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | −$0.08 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-07-01 to 2024-03-31 | −$0.29 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | −$0.08 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-07-01 to 2024-03-31 | −$0.29 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 12,175,195 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-07-01 to 2024-03-31 | 12,338,041 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-07-01 to 2024-03-31 | −$2.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-07-01 to 2024-03-31 | $316.9k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2023-07-01 to 2024-03-31 | $4.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-03-31 | $1.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $2.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $4.7m | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $646.3k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $1.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-03-31 | $3.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-24-041529. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.